TY - JOUR AU - Ho, S. M. PY - 2003 DA - 2003// TI - Estrogen, progesterone and epithelial ovarian cancer JO - Reprod Biol Endocrinol VL - 1 UR - https://doi.org/10.1186/1477-7827-1-73 DO - 10.1186/1477-7827-1-73 ID - Ho2003 ER - TY - JOUR AU - Moore, R. G. AU - Hill, E. K. AU - Horan, T. AU - Yano, N. AU - Kim, K. AU - MacLaughlan, S. PY - 2014 DA - 2014// TI - HE4 (WFDC2) gene overexpression promotes ovarian tumor growth JO - Sci Rep VL - 4 UR - https://doi.org/10.1038/srep03574 DO - 10.1038/srep03574 ID - Moore2014 ER - TY - JOUR AU - Gourley, C. PY - 2013 DA - 2013// TI - Hormone receptors and ovarian cancer survival JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70323-1 DO - 10.1016/S1470-2045(13)70323-1 ID - Gourley2013 ER - TY - JOUR AU - Haynes, B. P. AU - Viale, G. AU - Galimberti, V. AU - Rotmensz, N. AU - Gibelli, B. AU - A’Hern, R. PY - 2013 DA - 2013// TI - Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer JO - Breast Cancer Res Treat VL - 138 UR - https://doi.org/10.1007/s10549-013-2426-0 DO - 10.1007/s10549-013-2426-0 ID - Haynes2013 ER - TY - JOUR AU - Hein, A. AU - Thiel, F. C. AU - Bayer, C. M. AU - Fasching, P. A. AU - Haberle, L. AU - Lux, M. P. PY - 2013 DA - 2013// TI - Hormone replacement therapy and prognosis in ovarian cancer patients JO - Eur J Cancer Prev VL - 22 UR - https://doi.org/10.1097/CEJ.0b013e328355ec22 DO - 10.1097/CEJ.0b013e328355ec22 ID - Hein2013 ER - TY - JOUR AU - Treeck, O. AU - Pfeiler, G. AU - Mitter, D. AU - Lattrich, C. AU - Piendl, G. AU - Ortmann, O. PY - 2007 DA - 2007// TI - Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells JO - J Endocrinol VL - 193 UR - https://doi.org/10.1677/JOE-07-0087 DO - 10.1677/JOE-07-0087 ID - Treeck2007 ER - TY - JOUR AU - Sun, P. -. m. AU - Wei, L. -. h. AU - Sehouli, J. AU - Denkert, C. AU - Zhao, D. AU - Gao, M. PY - 2005 DA - 2005// TI - [Role of estrogen receptor-related receptors alpha, beta and gamma in ovarian cancer cells] JO - Zhonghua Fu Chan Ke Za Zhi VL - 40 ID - Sun2005 ER - TY - JOUR AU - Zhao, Z. -. N. AU - Zhou, Q. AU - Bai, J. -. X. AU - Yan, B. AU - Qin, W. -. W. AU - Wang, T. PY - 2011 DA - 2011// TI - Estrogen-induced dimerization and activation of ERalpha-fused caspase-8: artificial reversal of the estrogenic hormone effect in carcinogenesis JO - Cancer Biol Ther VL - 11 UR - https://doi.org/10.4161/cbt.11.9.15181 DO - 10.4161/cbt.11.9.15181 ID - Zhao2011 ER - TY - JOUR AU - Scott, A. AU - Weldon, S. AU - Taggart, C. C. PY - 2011 DA - 2011// TI - SLPI and elafin: multifunctional antiproteases of the WFDC family JO - Biochem Soc Trans VL - 39 UR - https://doi.org/10.1042/BST0391437 DO - 10.1042/BST0391437 ID - Scott2011 ER - TY - JOUR AU - Lu, L. AU - Katsaros, D. AU - Wiley, A. AU - Rigault Longrais, I. A. AU - Risch, H. A. AU - Puopolo, M. PY - 2006 DA - 2006// TI - The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1801 DO - 10.1158/1078-0432.CCR-05-1801 ID - Lu2006 ER - TY - JOUR AU - Sonnet, E. AU - Lacut, K. AU - Roudaut, N. AU - Mottier, D. AU - Kerlan, V. AU - Oger, E. PY - 2007 DA - 2007// TI - Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study JO - Clin Endocrinol (Oxf) VL - 66 UR - https://doi.org/10.1111/j.1365-2265.2007.02783.x DO - 10.1111/j.1365-2265.2007.02783.x ID - Sonnet2007 ER - TY - JOUR AU - Chen, Y. AU - Mu, X. AU - Wang, S. AU - Zhao, L. AU - Wu, Y. AU - Li, J. PY - 2013 DA - 2013// TI - WAP four-disulfide core domain protein 2 mediates the proliferation of human ovarian cancer cells through the regulation of growth- and apoptosis-associated genes JO - Oncol Rep VL - 29 ID - Chen2013 ER - TY - JOUR AU - Moore, R. G. AU - Miller, M. C. AU - Eklund, E. E. AU - Lu, K. H. AU - Bast, R. C. AU - Lambert-Messerlian, G. PY - 2012 DA - 2012// TI - Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age JO - Am J Obstet Gynecol VL - 206 ID - Moore2012 ER - TY - JOUR AU - Bouchard, D. AU - Morisset, D. AU - Bourbonnais, Y. AU - Tremblay, G. M. PY - 2006 DA - 2006// TI - Proteins with whey-acidic-protein motifs and cancer JO - Lancet Oncol VL - 7 UR - https://doi.org/10.1016/S1470-2045(06)70579-4 DO - 10.1016/S1470-2045(06)70579-4 ID - Bouchard2006 ER - TY - JOUR AU - Manolov, V. AU - Marinov, B. AU - Vasilev, V. AU - Andreeva, A. PY - 2011 DA - 2011// TI - [HE4--a new tumor marker for ovarian cancer] JO - Akush Ginekol (Sofiia) VL - 50 ID - Manolov2011 ER - TY - JOUR AU - Moore, R. G. AU - McMeekin, D. S. AU - Brown, A. K. AU - DiSilvestro, P. AU - Miller, M. C. AU - Allard, W. J. PY - 2009 DA - 2009// TI - A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass JO - Gynecol Oncol VL - 112 UR - https://doi.org/10.1016/j.ygyno.2008.08.031 DO - 10.1016/j.ygyno.2008.08.031 ID - Moore2009 ER - TY - JOUR AU - Zou, S. L. AU - Chang, X. H. AU - Ye, X. AU - Cheng, H. Y. AU - Cheng, Y. X. AU - Tang, Z. J. PY - 2011 DA - 2011// TI - Effect of human epididymis protein 4 gene silencing on the malignant phenotype in ovarian cancer JO - Chin Med J (Engl) VL - 124 ID - Zou2011 ER - TY - JOUR AU - Chen, H. 1. H. M. AU - Adams, J. S. PY - 2008 DA - 2008// TI - Control of estradiol-directed gene transactivation by an intracellular estrogen-binding protein and an estrogen response element-binding protein JO - Mol Endocrinol VL - 22 UR - https://doi.org/10.1210/me.2007-0297 DO - 10.1210/me.2007-0297 ID - Chen2008 ER - TY - JOUR AU - Lokich, E. AU - Singh, R. K. AU - Han, A. AU - Romano, N. AU - Yano, N. AU - Kim, K. PY - 2014 DA - 2014// TI - HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation JO - Sci Rep VL - 4 UR - https://doi.org/10.1038/srep05500 DO - 10.1038/srep05500 ID - Lokich2014 ER - TY - JOUR AU - Anastasi, E. AU - Granato, T. AU - Marchei, G. G. AU - Viggiani, V. AU - Colaprisca, B. AU - Comploj, S. PY - 2010 DA - 2010// TI - Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women JO - Tumour Biol VL - 31 UR - https://doi.org/10.1007/s13277-010-0049-1 DO - 10.1007/s13277-010-0049-1 ID - Anastasi2010 ER - TY - JOUR AU - Hua, W. AU - Christianson, T. AU - Rougeot, C. AU - Rochefort, H. AU - Clinton, G. M. PY - 1995 DA - 1995// TI - SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens JO - J Steroid Biochem Mol Biol VL - 55 UR - https://doi.org/10.1016/0960-0760(95)00187-5 DO - 10.1016/0960-0760(95)00187-5 ID - Hua1995 ER - TY - JOUR AU - Braicu, E. I. AU - Chekerov, R. AU - Richter, R. AU - Pop, C. AU - Nassir, M. AU - Loefgren, H. PY - 2014 DA - 2014// TI - HE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse JO - Ann Surg Oncol VL - 21 UR - https://doi.org/10.1245/s10434-013-3347-1 DO - 10.1245/s10434-013-3347-1 ID - Braicu2014 ER - TY - JOUR AU - O’Donnell, A. J. M. AU - Macleod, K. G. AU - Burns, D. J. AU - Smyth, J. F. AU - Langdon, S. P. PY - 2005 DA - 2005// TI - Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen JO - Endocr Relat Cancer VL - 12 UR - https://doi.org/10.1677/erc.1.01039 DO - 10.1677/erc.1.01039 ID - O’Donnell2005 ER - TY - JOUR AU - Belin, F. AU - Goudet, G. AU - Duchamp, G. AU - Gerard, N. PY - 2000 DA - 2000// TI - Intrafollicular concentrations of steroids and steroidogenic enzymes in relation to follicular development in the mare JO - Biol Reprod VL - 62 UR - https://doi.org/10.1095/biolreprod62.5.1335 DO - 10.1095/biolreprod62.5.1335 ID - Belin2000 ER - TY - JOUR AU - Fujiwara, T. AU - Lambert-Messerlian, G. AU - Sidis, Y. AU - Leykin, L. AU - Isaacson, K. AU - Toth, T. PY - 2000 DA - 2000// TI - Analysis of follicular fluid hormone concentrations and granulosa cell mRNA levels for the inhibin-activin-follistatin system: relation to oocyte and embryo characteristics JO - Fertil Steril VL - 74 UR - https://doi.org/10.1016/S0015-0282(00)00652-X DO - 10.1016/S0015-0282(00)00652-X ID - Fujiwara2000 ER - TY - JOUR AU - Felty, Q. AU - Singh, K. P. AU - Roy, D. PY - 2005 DA - 2005// TI - Estrogen-induced G1/S transition of G0-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1208667 DO - 10.1038/sj.onc.1208667 ID - Felty2005 ER - TY - JOUR AU - Frasor, J. AU - Gibori, G. PY - 2003 DA - 2003// TI - Prolactin regulation of estrogen receptor expression JO - Trends Endocrinol Metab VL - 14 UR - https://doi.org/10.1016/S1043-2760(03)00030-4 DO - 10.1016/S1043-2760(03)00030-4 ID - Frasor2003 ER - TY - JOUR AU - Bardin, A. AU - Hoffmann, P. AU - Boulle, N. AU - Katsaros, D. AU - Vignon, F. AU - Pujol, P. PY - 2004 DA - 2004// TI - Involvement of estrogen receptor beta in ovarian carcinogenesis JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-0552 DO - 10.1158/0008-5472.CAN-04-0552 ID - Bardin2004 ER - TY - JOUR AU - Mahran, Y. F. AU - El-Demerdash, E. AU - Nada, A. S. AU - Ali, A. A. AU - Abdel-Naim, A. B. PY - 2013 DA - 2013// TI - Insights into the protective mechanisms of tamoxifen in radiotherapy-induced ovarian follicular loss: impact on insulin-like growth factor 1 JO - Endocrinology VL - 154 UR - https://doi.org/10.1210/en.2013-1214 DO - 10.1210/en.2013-1214 ID - Mahran2013 ER - TY - JOUR AU - Hwang, K. -. A. AU - Park, M. -. A. AU - Kang, N. -. H. AU - Yi, B. -. R. AU - Hyun, S. -. H. AU - Jeung, E. -. B. PY - 2013 DA - 2013// TI - Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 beta-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor alpha and insulin-like growth factor-1 receptor signaling pathways JO - Toxicol Appl Pharmacol VL - 272 UR - https://doi.org/10.1016/j.taap.2013.07.027 DO - 10.1016/j.taap.2013.07.027 ID - Hwang2013 ER - TY - JOUR AU - Grimberg, A. 1. C. P. PY - 2000 DA - 2000// TI - Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis JO - J Cell Physiol VL - 183 UR - https://doi.org/3.0.CO;2-J DO - 3.0.CO;2-J ID - Grimberg2000 ER - TY - JOUR AU - Song, T. F. AU - Zhang, Z. F. AU - Liu, L. AU - Yang, T. AU - Jiang, J. AU - Li, P. PY - 2009 DA - 2009// TI - Small interfering RNA-mediated silencing of heat shock protein 27 (HSP27) Increases chemosensitivity to paclitaxel by increasing production of reactive oxygen species in human ovarian cancer cells (HO8910) JO - J Int Med Res VL - 37 UR - https://doi.org/10.1177/147323000903700512 DO - 10.1177/147323000903700512 ID - Song2009 ER - TY - JOUR AU - Pai, H. C. AU - Kumar, S. AU - Shen, C. C. AU - Liou, J. P. AU - Pan, S. L. AU - Teng, C. M. PY - 2015 DA - 2015// TI - MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27 JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0123819 DO - 10.1371/journal.pone.0123819 ID - Pai2015 ER - TY - JOUR AU - Miyamoto, M. T. M. AU - Iwaya, K. AU - Shinomiya, N. AU - Kato, M. AU - Aoyama, T. AU - Sasaki, N. PY - 2014 DA - 2014// TI - X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary JO - Br J Cancer VL - 110 UR - https://doi.org/10.1038/bjc.2014.255 DO - 10.1038/bjc.2014.255 ID - Miyamoto2014 ER - TY - JOUR AU - Obexer, P. A. M. PY - 2014 DA - 2014// TI - X-linked inhibitor of apoptosis protein - a critical death resistance regulator and therapeutic target for personalized cancer therapy JO - Front Oncol VL - 28 ID - Obexer2014 ER - TY - JOUR AU - Zhu, J. AU - Lu, X. AU - Hua, K. -. Q. AU - Sun, H. AU - Yu, Y. -. H. AU - Feng, Y. -. J. PY - 2012 DA - 2012// TI - Oestrogen receptor alpha mediates 17beta-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression JO - Arch Gynecol Obstet VL - 286 UR - https://doi.org/10.1007/s00404-012-2368-5 DO - 10.1007/s00404-012-2368-5 ID - Zhu2012 ER - TY - JOUR AU - Suzuki, H. AU - Emi, M. AU - Komiya, A. AU - Fujiwara, Y. AU - Yatani, R. AU - Nakamura, Y. PY - 1995 DA - 1995// TI - Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3 JO - Genes Chromosomes Cancer VL - 13 UR - https://doi.org/10.1002/gcc.2870130306 DO - 10.1002/gcc.2870130306 ID - Suzuki1995 ER - TY - JOUR AU - Zurawa-Janicka, D. AU - Skorko-Glonek, J. AU - Lipinska, B. PY - 2010 DA - 2010// TI - HtrA proteins as targets in therapy of cancer and other diseases JO - Expert Opin Ther Targets VL - 14 UR - https://doi.org/10.1517/14728222.2010.487867 DO - 10.1517/14728222.2010.487867 ID - Zurawa-Janicka2010 ER - TY - JOUR AU - Chien, J. AU - Campioni, M. AU - Shridhar, V. AU - Baldi, A. PY - 2009 DA - 2009// TI - HtrA serine proteases as potential therapeutic targets in cancer JO - Curr Cancer Drug Targets VL - 9 UR - https://doi.org/10.2174/156800909788486704 DO - 10.2174/156800909788486704 ID - Chien2009 ER - TY - JOUR AU - Bansal, N. AU - Marchion, D. C. AU - Bicaku, E. AU - Xiong, Y. AU - Chen, N. AU - Stickles, X. B. PY - 2012 DA - 2012// TI - BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin JO - J Gynecol Oncol VL - 23 UR - https://doi.org/10.3802/jgo.2012.23.1.35 DO - 10.3802/jgo.2012.23.1.35 ID - Bansal2012 ER - TY - JOUR AU - Thomadaki, H. AU - Scorilas, A. PY - 2006 DA - 2006// TI - BCL2 family of apoptosis-related genes: functions and clinical implications in cancer JO - Crit Rev Clin Lab Sci VL - 43 UR - https://doi.org/10.1080/10408360500295626 DO - 10.1080/10408360500295626 ID - Thomadaki2006 ER -